| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Global Head of R&D | President, R&D | Director
2 companies
Cagnoni Pablo J is a President, Global Head of R&D at INCY, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 15 sales. Those positions are worth an estimated $13.2M at current prices.
Cagnoni Pablo J's largest disclosed position is in INCY as President, Global Head of R&D, worth about $13.2M. The recent filings there lean toward selling, a net 129,994 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | INCY Incyte Corporation | President, Global Head of R&D | Sale+OE10b5-1 | 2,642 | $112.71 | $297,779.82 | -1.4% | - | - | |
| Sep 15, 2026 | INCY Incyte Corporation | President, Global Head of R&D | Sale+OE10b5-1 | 23,218 | $120.49 | $2,797,629.15 | -11.2% | - | - | |
| Aug 19, 2026 | INCY Incyte Corporation | President, Global Head of R&D | Sell10b5-1 | 10,801 | $125.56 | $1,356,173.56 | -5.6% | - | - | |
| Aug 12, 2026 | INCY Incyte Corporation | President, Global Head of R&D | Sell10b5-1 | 10,803 | $120.04 | $1,296,792.12 | -5.3% | - | - | |
| Aug 5, 2026 | INCY Incyte Corporation | President, Global Head of R&D | Sell10b5-1 | 10,640 | $122.69 | $1,305,421.60 | -4.9% | - | - | |
| Jul 31, 2026 | INCY Incyte Corporation | President, Global Head of R&D | Sell10b5-1 | 15,888 | $119.70 | $1,901,793.60 | -6.9% | - | - | |
| Apr 17, 2026 | INCY Incyte Corporation | President, Global Head of R&D | Sale+OE10b5-1 | 18,667 | $96.50 | $1,801,365.50 | -6.6% | +19.2% | - | |
| Mar 17, 2026 | INCY Incyte Corporation | President, R&D | Sale+OE10b5-1 | 18,667 | $94.24 | $1,759,178.08 | -7.4% | +8.2% | - | |
| Feb 19, 2026 | INCY Incyte Corporation | President, R&D | Sale+OE10b5-1 | 18,668 | $100.91 | $1,883,787.88 | -7.4% | -4.6% | - | |
| Nov 19, 2019 | CRSP Crispr Therapeutics AG | Director | Sale+OE | 7,500 | $62.00 | $465,000.00 | - | - | - |